Practical Considerations for the Management of Cushing's Disease and COVID-19: A Case Report

Conclusion: Adrenal insufficiency might be a clinical challenge that needs a prompt treatment also in CS patients during COVID-19 infection. We should consider the possibility to titrate or temporary halt medical therapies of CS in the context of COVID-19 infection. Unexpected hyperkalemia in CS patients under treatment with heparin might be the signal of aldosterone suppression.
Source: Frontiers in Endocrinology - Category: Endocrinology Source Type: research